Evaluation of AI for prostate cancer detection in biparametric-MRI screening population data - Top-Institutions - MDSpire

Evaluation of AI for prostate cancer detection in biparametric-MRI screening population data

  • By

  • Fredrik Langkilde

  • Magnus Gren

  • Jonas Wallström

  • Stefan Kuczera

  • Stephan E. Maier

  • December 8, 2025

  • 0 min

Share

Top Institutions in Radiology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Radiology
    • Urologic Oncology
    • Medical AI Research

  • #2

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Radiology
    • Urology
    • Biomedical Informatics

  • #3

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, N/A

    Key Differentiators

    • Radiology
    • Oncology
    • Medical AI

  • #4

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Cancer Imaging
    • Oncology Research
    • AI in Medicine

  • #5

    University of Cambridge
    University of Cambridge

    Cambridge, N/A

    Key Differentiators

    • Radiology
    • Oncology
    • Computational Medicine

Original Source(s)

Evaluation of AI for prostate cancer detection in biparametric-MRI screening population data

  • by Fredrik Langkilde, Magnus Gren, Jonas Wallström, Stefan Kuczera, Stephan E. Maier

  • December 8, 2025

Related Content

Mammography AI Spots Vascular Signals

Routine breast imaging offers opportunity for cardiovascular risk assessment.

Diagnostic accuracy of deep learning vs. human raters for detecting osteoporotic vertebral compression fractures in routine CT scans

Evaluation of an artificial intelligence model based on multiparametric transrectal ultrasound for localizing clinically significant prostate cancer by simulation of targeted biopsies